Continuous Glucose Monitoring Systems Market - Global Forecast 2025-2032

Continuous glucose monitoring systems are transforming real-time diabetes management, offering actionable insights for healthcare executives focused on streamlining chronic care pathways and achieving greater operational value.

Market Snapshot: Continuous Glucose Monitoring Systems Market

The Continuous Glucose Monitoring Systems Market expanded from USD 4.47 billion in 2024 to USD 4.79 billion in 2025 and is forecasted to grow at a CAGR of 7.44%, reaching USD 7.95 billion by 2032. This substantial growth is driven by ongoing advancements in monitoring technology, widening clinical applications, and the increasing integration of data-centric healthcare models. The market is seeing robust momentum from new patient management platforms, alongside close collaboration between device manufacturers and healthcare providers, ensuring that digital solutions support improved patient outcomes and workflow efficiency.

Scope & Segmentation

• Component: Receivers/Monitors, Sensors, and Transmitters each deliver essential capabilities within the continuous glucose monitoring ecosystem, from capturing glucose data to ensuring reliable real-time transmission for both patients and clinicians.
• Type of Device: Integrated CGM Systems and Standalone CGM Systems, allowing clinics aiming for cohesive workflow integration and individuals requiring flexible modular upgrades to address evolving clinical needs.
• Duration of Use: Long-Term Implantable CGMs and Short-Term Wearable CGMs let users select devices based on preferences, from continuous multi-month monitoring to temporary solutions for intensive short-term management.
• Patient Age Group: Adults, Children, and Geriatric populations, each benefitting from features such as ergonomic design, ease of calibration, or customizable alerts for age-specific monitoring challenges.
• Application: Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes are addressed by specialized device use-cases, supporting hospital strategies around maternal care and cost management in chronic care settings.
• Distribution Channel: Offline options such as clinical retailers and pharmacies, and Online options including eCommerce platforms and manufacturer direct channels, together extend accessibility across multiple healthcare delivery formats and user types.
• End User: Ambulatory Surgical Centers, Home Care Settings, and Hospitals & Clinics utilize continuous glucose monitoring systems to support inpatients, outpatients, and at-home users seeking ongoing glucose management.
• Region: Americas (North and Latin America), Europe, Middle East & Africa (with detailed subregional analysis), and Asia-Pacific, reflecting the market’s expanding global footprint and the differing adoption speeds in established and emerging markets.
• Leading Companies: Principal market players include A. Menarini Diagnostics s.r.l, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Dexcom Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, NXP Semiconductors N.V., Senseonics Holdings Inc., Sibionics, Signos, Inc., STMicroelectronics N.V., Tandem Diabetes Care, Inc., Texas Instruments Incorporated, and Ypsomed Holding AG.

Key Takeaways: Strategic Insights for Continuous Glucose Monitoring

• Continuous glucose monitoring delivers robust, real-time data streams that empower personalized treatment plans and help boost patient engagement across care settings.
• Advances in device miniaturization increase user comfort and facilitate remote patient monitoring, leading to more streamlined workflows for clinical teams.
• Collaborative market activity supports the rapid adoption of closed-loop systems, enhancing metabolic control for diverse patient populations.
• Regulatory and reimbursement developments now accelerate competition and innovation, supporting the introduction of advanced systems in a broader range of care environments.
• Segment-specific device choices, such as long-term implants for geriatric users and wearables for active individuals, drive differentiated adoption patterns by clinical need and age group.
• Distribution strategies increasingly blend robust online and brick-and-mortar channels, expanding access and market reach for device manufacturers and healthcare providers.

Tariff Impact on Supply Chains

As of 2025, additional United States tariffs have introduced added complexity in the supply chain for sensors and transmitters. To maintain competitive pricing and supply stability, manufacturers are focusing on nearshoring, forming new domestic partnerships, and investing in automation. Enhanced supplier management, flexible procurement strategies, and technology-enabled supply chains are now instrumental in mitigating both regulatory and cost pressures, ultimately shaping new standards for market agility and value delivery.

Methodology & Data Sources

The report utilizes a comprehensive research framework, including interviews with endocrinologists, nurses, procurement professionals, and technology specialists to validate and interpret emerging trends. Secondary sources are leveraged from peer-reviewed research, regulatory records, company filings, and authoritative industry publications, with quantitative analysis ensuring the reliability of all findings.

Why This Report Matters

• Enables healthcare executives and technology leaders to identify growth areas and innovation opportunities within continuous glucose monitoring systems and adjacent clinical technology.
• Clarifies operational strategies by mapping regulatory shifts, supply chain changes, and market expansions that influence technology adoption and resource planning.
• Provides a strategic overview of competitor initiatives and pipeline developments, equipping organizations to anticipate emerging stakeholder and patient needs.

Conclusion

This report provides a clear framework for leveraging technology, strategic partnerships, and market dynamics to advance the adoption of continuous glucose monitoring systems. Senior leaders will find actionable insights for optimizing deployment and ensuring sustainable growth in an evolving healthcare landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.